Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May;24(5):e189.
doi: 10.1016/S1470-2045(23)00122-5.

Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm

Thorvardur R Halfdanarson  1 , Travis E Grotz  2 , Hallbera Gudmundsdottir  2 , Sean P Cleary  2
Affiliations
Comment

Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm

Thorvardur R Halfdanarson et al. Lancet Oncol. 2023 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

TRH has received research support paid to their institution from Thermo Fisher Scientific, Isotopen Technologien Muenchen (ITM), Crinetics, Camurus, and Advanced Accelerator Applications (a Novartis company); consulting fees for participation on advisory boards from TerSera and Terumo; participation on advisory boards with ITM (paid to institution), Crinetics (unpaid), Camurus (paid to institution), Advanced Accelerator Applications (a Novartis company), Ipsen (paid to institution), and TerSera (personal fees); travel fees paid for attending an investigator meeting or steering committee meeting from Camurus; and being Vice President of the North American Neuroendocrine Tumor Society (unpaid). TEG reports a research grant to institution from Intuitive and institutional participation in a data safety monitoring board for Mayo Clinic Comprehensive Cancer Center (unpaid). HG and SPC declare no competing interests.

Comment in

Comment on

  • Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
    Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift AK, Clouston H, Cobianchi L, Ćwikła JB, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P, Inzani F, Jann H, Jimenez-Fonseca P, Kaçmaz E, Kaemmerer D, Kaltsas G, Klimacek B, Knigge U, Kolasińska-Ćwikła A, Kolb W, Kos-Kudła B, Kunze CA, Landolfi S, La Rosa S, López CL, Lorenz K, Matter M, Mazal P, Mestre-Alagarda C, Del Burgo PM, van Dijkum EJMN, Oleinikov K, Orci LA, Panzuto F, Pavel M, Perrier M, Reims HM, Rindi G, Rinke A, Rinzivillo M, Sagaert X, Satiroglu I, Selberherr A, Siebenhüner AR, Tesselaar MET, Thalhammer MJ, Thiis-Evensen E, Toumpanakis C, Vandamme T, van den Berg JG, Vanoli A, van Velthuysen MF, Verslype C, Vorburger SA, Lugli A, Ramage J, Zwahlen M, Perren A, Kaderli RM. Nesti C, et al. Lancet Oncol. 2023 Feb;24(2):187-194. doi: 10.1016/S1470-2045(22)00750-1. Epub 2023 Jan 11. Lancet Oncol. 2023. PMID: 36640790

LinkOut - more resources